dronabinol has been researched along with fentanyl in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Auld, DS; Austin, CP; Huang, R; Moeller, TA; Sakamuru, S; Shinn, P; Shukla, SJ; Vanleer, D; Xia, M | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Cheng, J; McCorvy, JD; Tan, L; Yan, W | 1 |
| Daskalopoulos, N; Laubie, M; Schmitt, H | 1 |
| Cao, XD; Mo, WY; Pan, YY; Xu, SF; Xu, ZB | 1 |
| Uhl, M | 1 |
| Clarke, RW; Harris, J; Jenkins, S; Witton, SK | 1 |
| Cichewicz, DL; Smith, FL; Welch, SP | 1 |
| Bermejo, AM; Botrè, F; de la Torre, X; Strano-Rossi, S | 1 |
| France, CP; Maguire, DR | 1 |
| Dempsey, SK; Gray, TR; Kelly, AT; Lee, D; Stout, P | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
| Barkholtz, H; Miles, A; Pieters, R; Sanders, T; Savage, T | 1 |
| Carey, LM; France, CP; Maguire, DR | 1 |
1 review(s) available for dronabinol and fentanyl
| Article | Year |
|---|---|
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship | 2018 |
18 other study(ies) available for dronabinol and fentanyl
| Article | Year |
|---|---|
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identification of clinically used drugs that activate pregnane X receptors.
Topics: Animals; Cell Line, Tumor; Cytochrome P-450 CYP3A; Drug Interactions; Hep G2 Cells; Hepatocytes; Humans; Pharmaceutical Preparations; Pregnane X Receptor; Rats; Receptors, Steroid; Small Molecule Libraries; Species Specificity; Structure-Activity Relationship; Xenobiotics | 2011 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
[Action of delta 9 tetrahydrocannabinol on the central cardiovascular regulation : mechanism and localization].
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cannabis; Cardiovascular System; Cats; Clonidine; Dogs; Dronabinol; Electric Stimulation; Evoked Potentials; Fentanyl; Heart Rate; Hypothalamus; Medulla Oblongata; Morphine Derivatives; Nalorphine; Naloxone; Sciatic Nerve; Splanchnic Nerves; Spleen | 1975 |
Effect of combination of drugs with acupuncture on analgesic efficacy.
Topics: Acupuncture Analgesia; Analgesics; Animals; Combined Modality Therapy; Diazepam; Dronabinol; Droperidol; Fenfluramine; Fentanyl; Humans; Ketamine; Pain Management; Perphenazine; Rabbits; Sulpiride | 1989 |
Determination of drugs in hair using GC/MS/MS.
Topics: Adult; Azaperone; Child; Dronabinol; Fentanyl; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Hypnotics and Sedatives; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Sufentanil; Tramadol | 1997 |
Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit.
Topics: Animals; Decerebrate State; Dose-Response Relationship, Drug; Dronabinol; Female; Fentanyl; Male; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rabbits; Receptors, Cannabinoid; Receptors, Drug; Reflex; Rimonabant; Spinal Cord; Spinal Cord Injuries | 2001 |
Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol.
Topics: Administration, Cutaneous; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Buprenorphine; Dronabinol; Drug Synergism; Female; Fentanyl; Guinea Pigs; Pain Measurement | 2005 |
Fast GC-MS method for the simultaneous screening of THC-COOH, cocaine, opiates and analogues including buprenorphine and fentanyl, and their metabolites in urine.
Topics: Buprenorphine; Cocaine; Dronabinol; Fentanyl; Gas Chromatography-Mass Spectrometry; Humans | 2011 |
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.
Topics: Animals; Cannabinoid Receptor Agonists; Cyclohexanols; Discrimination, Psychological; Dronabinol; Drug Interactions; Female; Fentanyl; Macaca mulatta; Nalbuphine; Receptors, Opioid, mu | 2016 |
A Comparison of High Drug Concentrations in Impaired Driving and Postmortem Casework in Harris County, TX.
Topics: Automobile Driving; Clonazepam; Driving Under the Influence; Dronabinol; Ethanol; Fentanyl; Hydrocodone; Methamphetamine; Oxycodone; Substance Abuse Detection | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Suitability of SoToxa® Oral Fluid Screening Over Time: Re-Examination of Drugged Driving in Wisconsin.
Topics: Amphetamine; Analgesics, Opioid; Benzodiazepines; Clonazepam; Cocaine; Diazepam; Dronabinol; Fentanyl; Humans; Methamphetamine; Reproducibility of Results; Saliva; Substance Abuse Detection; Wisconsin | 2022 |
Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Fentanyl; Hallucinogens; Macaca mulatta | 2023 |